FDA officials: UDI system a must to improve device surveillance

In a commentary posted this week in the New England Journal of Medicine, Thomas Gross, M.D. and Jay Crowley, M.S.--officials from the Food and Drug Administration--argue that a unique device identification system is necessary to improve the post-market surveillance of medical devices. "We believe that [a new UDI system] will benefit all stakeholders in the healthcare system--patients, clinicians, hospital systems, health insurers, the medical device industry and the FDA--in a number of ways," Gross and Crowley wrote. Chief among those benefits, they say--more accurate and timely reporting of adverse events. Commentary

Suggested Articles

Key lawmakers are fed up with what they see as poor VA leadership over a new Cerner EHR system and vowed to take tighter control of the project.

Teladoc is playing an active role in preparations for a potential U.S. coronavirus outbreak and is working with the CDC to help track diseases.

Blue Shield of California is teaming up with Accolade to offer self-insured employers a personalized way to connect with members about their benefits.